QH-1A Hybrid Bio-Artificial Liver With Ex Vivo Blood-Purifying MSCs

· Third Affiliated Hospital, Sun Yat-Sen University

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for QH-1A Hybrid Bio-Artificial Liver With Ex Vivo Blood-Purifying MSCs, covering 2025-05-30 to 2025-05-30. Get the full timeline:

Most recent: Clinical Trial Update: Phase I Trial of QH-1A Hybrid Bio-Artificial Liver With Ex Vivo Blood-Purifying MSCs in Acute-on-Chronic Liver Failure [Phase 1]

See pricing